Open AccessLong-term outcomes in patients after left atrial appendage occlusion: The results from the LAAO SILESIA registry
Author(s) -
Krzysztof Myrda,
Witold Streb,
Wojciech Wojakowski,
Jacek Piegza,
Katarzyna Mitręga,
Grzegorz Smołka,
Jolanta Nowak,
Tomasz Podolecki,
Ewa Gasiewska-Żurek,
Alicja NowowiejskaWiewióra,
Malwina Smolarek-Nicpoń,
Michał Skrzypek,
Mariusz Gąsior,
Zbigniew Kalarus
Publication year - 2022
Publication title -
kardiologia polska
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.527
H-Index - 34
eISSN - 1897-4279
pISSN - 0022-9032
DOI - 10.33963/kp.a2022.0047
Subject(s) - medicine , left atrial appendage occlusion , stroke (engine) , pericardial effusion , adverse effect , percutaneous , cohort , surgery , population , atrial fibrillation , occlusion , emergency medicine , warfarin , mechanical engineering , environmental health , engineering
The benefits of oral anticoagulation (OAC) therapy are undeniable. However, such treatment is contraindicated in 2%-10% of patients. According to the latest guidelines, percutaneous left atrial appendage occlusion (LAAO) may be considered in stroke prevention.